Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent pulmonary hypertension in preterm-infants.

M Amato, B de Roche, G von Muralt

    Padiatrie Und Padologie
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for Atomic-Scale Vibron-Mediated Electron Bunching.

    Physical review letters·2026
    Same author

    The Reproductive Mental health of Ontario Virtual Intervention Network (MOVIN): a pilot randomized controlled trial.

    Communications medicine·2026
    Same author

    Rare perinephric myxoid pseudotumor of fat causing ureteropelvic junction obstruction: a case report.

    CEN case reports·2022
    Same author

    Clinical characterization of gingival type of burning mouth syndrome: a cross-sectional study.

    Medicina oral, patologia oral y cirugia bucal·2021
    Same author

    Modelling approach to obtain regional respiratory mechanics using electrical impedance tomography and volume-dependent elastance model.

    Physiological measurement·2019
    Same author

    Q fever outbreak among travelers to Germany associated with live cell therapy - United States and Canada, 2014: a co-publication.

    Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
    Same journal

    [Is the Supply of Medicines in Danger?]

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    See all related articles

    Persistent pulmonary hypertension of the newborn (PPHN) affects term and preterm infants. In preterm infants, PPHN is functional, resolves quickly with early diagnosis and treatment, and requires specialized neonatal care.

    Area of Science:

    • Neonatology
    • Pediatric Cardiology
    • Pulmonology

    Background:

    • Persistent pulmonary hypertension of the newborn (PPHN) is a cyanotic syndrome in term and postmature infants.
    • PPHN in term infants involves structural changes in pulmonary vascular smooth muscle due to prenatal distress.
    • The study posits that PPHN also occurs in preterm infants.

    Purpose of the Study:

    • To describe the characteristics of PPHN in preterm infants.
    • To differentiate the pathophysiology of PPHN between term and preterm neonates.
    • To emphasize the importance of early diagnosis and specialized care for PPHN in preterm infants.

    Main Methods:

    • Clinical observation and case review of preterm infants with PPHN.
    • Comparison of clinical presentation and response to treatment in term versus preterm infants with PPHN.

    Related Experiment Videos

  • Review of potential pathophysiological mechanisms in preterm PPHN.
  • Main Results:

    • PPHN in preterm infants is characterized by functional pulmonary vascular changes, not structural ones.
    • Cyanosis in preterm infants with PPHN is rapidly regredient.
    • Clinical resolution is prompt with accurate diagnosis and timely, specialized care.

    Conclusions:

    • PPHN is a syndrome that can affect preterm infants through functional vascular changes.
    • Early diagnosis and intervention in specialized centers are crucial for favorable outcomes in preterm PPHN.
    • Neonatal supportive care and monitoring are essential, particularly when considering therapies like Tolazoline.